Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tab

Active, not recruitingOBSERVATIONAL

Enrollment

2,845

Participants

Timeline

Start Date

June 20, 2022

Primary Completion Date

March 31, 2025

Study Completion Date

December 31, 2025

Conditions

HyperlipidemiasHypertension

Interventions

DRUG

Rosuvastatin, Olmesartan Medoxomil

Olostar Tablet

Trial Locations (1)

Severance Hospital, Seoul